Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

FRESENIUS MEDICAL CARE AG & CO. KGAA

(FME)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
07/19/2021 07/20/2021 07/21/2021 07/22/2021 07/23/2021 Date
68.7(c) 67.72(c) 68.26(c) 69.24(c) 69.38(c) Last
444 528 385 289 515 342 349 833 410 872 Volume
-1.58% -1.43% +0.80% +1.44% +0.20% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 21 435 M - -
Net income 2021 1 308 M - -
Net Debt 2021 13 546 M - -
P/E ratio 2021 18,4x
Yield 2021 1,74%
Sales 2022 22 479 M - -
Net income 2022 1 531 M - -
Net Debt 2022 13 005 M - -
P/E ratio 2022 15,6x
Yield 2022 1,92%
Capitalization 23 913 M 23 904 M -
EV / Sales 2021 1,75x
EV / Sales 2022 1,64x
Nbr of Employees 124 995
Free-Float 67,8%
More Financials
Company
Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines,... 
More about the company
Ratings of Fresenius Medical Care AG & Co. KGaA
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about FRESENIUS MEDICAL CARE AG & CO. KGAA
07/23FMC FRESENIUS MEDICAL CARE AG & CO K : Jefferies gives a Sell rating
MD
07/23FRESENIUS SE : Jefferies reiterates its Sell rating
MD
07/21FMC FRESENIUS MEDICAL CARE AG & CO K : Goldman Sachs maintains a Buy rating
MD
07/21FRESENIUS SE : JP Morgan maintains a Buy rating
MD
07/20FMC FRESENIUS MEDICAL CARE AG & CO K : JP Morgan gives a Neutral rating
MD
07/20FRESENIUS SE : Berenberg remains its Buy rating
MD
07/20FMC FRESENIUS MEDICAL CARE AG & CO K : Receives a Buy rating from Berenberg
MD
07/14FRESENIUS MEDICAL CARE : Truist Securities Adjusts Fresenius Medical Care PT to ..
MT
07/14FMC FRESENIUS MEDICAL CARE AG & CO K : Gets a Neutral rating from Morgan Stanley
MD
07/14FRESENIUS SE : Morgan Stanley maintains a Buy rating
MD
07/13FRESENIUS MEDICAL CARE : Xenios AG receives approval in China for ECMO devices
BU
07/08EXCLUSIVE : German artificial limb maker Ottobock plans blockbuster 2022 IPO - s..
RE
07/07DGAP-PVR : Fresenius Medical Care AG & Co. KGaA: Release according to Article 40..
DJ
07/06FMC FRESENIUS MEDICAL CARE AG & CO K : JP Morgan remains Neutral
MD
07/06FRESENIUS SE : JP Morgan reiterates its Buy rating
MD
More news
News in other languages on FRESENIUS MEDICAL CARE AG & CO. KGAA
07/2319 TERMINE, die in der Woche wichtig werden (Donnerstag/Freitag)
07/23GLAXOSMITHKLINE IM FOKUS : Auf dem Weg zur Aufspaltung
07/16MÄRKTE EUROPA/Kaum Bewegung bei Aktien - Jenoptik sehr fest
07/15MÄRKTE EUROPA/Gute Vorlagen für DAX - Daimler mit guten Zahlen
07/14MÄRKTE EUROPA/Seitwärts - Ausbruch auf der Oberseite drin
More news
Analyst Recommendations on FRESENIUS MEDICAL CARE AG & CO. KGAA
More recommendations
Chart FRESENIUS MEDICAL CARE AG & CO. KGAA
Duration : Period :
Fresenius Medical Care AG & Co. KGaA Technical Analysis Chart | FME | DE0005785802 | MarketScreener
Technical analysis trends FRESENIUS MEDICAL CARE AG & CO. KGAA
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 21
Last Close Price 81,65 $
Average target price 81,39 $
Spread / Average Target -0,32%
EPS Revisions
Managers and Directors
Rice Powell Chief Executive Officer
Helen Giza Chief Financial Officer
Dieter Schenk Chairman-Supervisory Board
Olaf Schermeier CEO-Global Research & Development
Franklin W. Maddux Global Chief Medical Officer